Eli Lilly Stock - Weekly review after strong obesity and diabetes momentum
21.06.2026 - 22:50:02 | ad-hoc-news.de
Edited by ad hoc news Sector & Peer-Group Desk. Verified prior to publication on 06/21/2026, 20:44 UTC. Details in the imprint.
Eli Lilly and Company (US5324571083) has closed the week with its stock trading just below recent highs, underpinned by strong demand for its obesity and diabetes treatments. The weekly picture is dominated by robust fundamentals and ongoing optimism about its GLP-1 drug franchise, as recent analyst data show.
All news and analysis on Eli Lilly stock
Key figures, filings and news on Eli Lilly's high-valuation pharma stock, including updates on obesity and diabetes drugs.
How Eli Lilly shares ended the week
On the New York Stock Exchange, Eli Lilly shares last closed at $1,098.78 on 06/18/2026, implying a market capitalization slightly above $1.0 trillion, according to recent quote data. MarketBeat quote page
Other data providers show Eli Lilly stock around $1,099 with the shares up just over 3% over the past 30 days, highlighting a still-firm upward trend despite some short-term volatility. TrendSpider overview
Weekly review and sector comparison
In the wider US pharma and biotech space, Eli Lilly has continued to stand out for its high valuation and size, with a trailing price-to-earnings ratio near 39 based on one recent data snapshot. TradingKey data
Net-net, this places Lilly at a premium to many large-cap peers, reflecting investor confidence in the long-term earnings power of its GLP-1 drugs compared with more mature portfolios at legacy competitors.
What the company sells
Eli Lilly generates most of its revenue from prescription medicines, with obesity and diabetes therapies such as Mounjaro (tirzepatide) and Zepbound, alongside treatments in oncology, immunology and neuroscience, forming its current growth engine.
Where the stock trades today
The shares of Eli Lilly and Company (US5324571083) last traded on the New York Stock Exchange at $1,098.78 as of 06/18/2026, 16:00 ET.
Key facts on Eli Lilly stock
- Company: Eli Lilly and Company
- ISIN: US5324571083
- WKN: 858560
- Ticker: LLY
- Venue: NYSE
- Price (as of 06/18/2026, 16:00 ET): 1,098.78 USD
- Market cap: 1,030,000,000,000 USD (as of 06/18/2026)
- Sector / Industry: Health Care / Pharmaceuticals
- Index membership: S&P 500
- Next earnings date: 08/06/2026
This article was AI-assisted and editorially reviewed. Price and company data without warranty; prices and dates may change at short notice. No investment advice, no buy or sell recommendation. Trading securities involves risk up to total loss of capital.
